Membrane glycoprotein nectin-4 in tumor associated pathways and anti-cancer therapeutics

Namrata Ganguli1, Sarbartha Mukherjee1, Dibyendu Samanta1

  • 1Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, 721302, West Bengal, India.

Insights

Nectin-4, a tumor antigen, is highly expressed in cancers but not healthy tissues, making it a promising target for cancer diagnostics and therapeutics. Its role extends to embryonic development and infectious diseases.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Nectin-4 is a cell adhesion molecule (CAM) belonging to the immunoglobulin superfamily.
  • It is increasingly recognized as a tumor-associated antigen with significant implications in cancer biology.
  • Nectin-4 plays roles in embryonic development and infectious diseases, indicating broader biological relevance.

Purpose of the Study:

  • To review the multifaceted role of nectin-4 in cancer progression.
  • To analyze the expression patterns of nectin-4 across various cancer types.
  • To highlight therapeutic strategies targeting nectin-4 and its diagnostic potential.

Main Methods:

  • Literature review focusing on nectin-4's role in cancer.
  • Analysis of molecular mechanisms and cell-signaling pathways involving nectin-4.
  • Categorical documentation and analysis of nectin-4 expression data in cancer.

Main Results:

  • Nectin-4 exhibits enhanced expression in various cancers, contrasting with its minimal presence in healthy adult tissues.
  • The extracellular domain of nectin-4 is shed, enabling its use as a serological cancer marker.
  • Nectin-4 is implicated in cancer progression through various pathophysiological aspects and cell-signaling pathways.

Conclusions:

  • Nectin-4 is a crucial target for developing novel anti-cancer therapeutics and diagnostic tools.
  • Understanding nectin-4's molecular mechanisms is vital for advancing cancer research.
  • Nectin-4's involvement in embryonic development and infectious diseases underscores its holistic significance in human health.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K